Joanne D Stekler1, Joshua D O'Neal2, Aric Lane3, Fred Swanson4, Janine Maenza2, Claire E Stevens2, Robert W Coombs5, Joan A Dragavon6, Paul D Swenson3, Matthew R Golden7, Bernard M Branson8. 1. Department of Medicine, University of Washington, Seattle, WA, United States; Department of Epidemiology, University of Washington, Seattle, WA, United States; Public Health - Seattle & King County, Seattle, WA, United States. Electronic address: jstekler@uw.edu. 2. Department of Medicine, University of Washington, Seattle, WA, United States. 3. Public Health - Seattle & King County, Seattle, WA, United States. 4. Gay City Health Project, Seattle, WA, United States. 5. Department of Medicine, University of Washington, Seattle, WA, United States; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States. 6. Department of Laboratory Medicine, University of Washington, Seattle, WA, United States. 7. Department of Medicine, University of Washington, Seattle, WA, United States; Department of Epidemiology, University of Washington, Seattle, WA, United States; Public Health - Seattle & King County, Seattle, WA, United States. 8. Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Abstract
BACKGROUND: Point-of-care (POC) rapid HIV tests have sensitivity during the "window period" comparable only to earliest generation EIAs. To date, it is unclear whether any POC test performs significantly better than others. OBJECTIVE: Compare abilities of POC tests to detect early infection in real time. STUDY DESIGN: Men who have sex with men (MSM) were recruited into a prospective, cross-sectional study at two HIV testing sites and a research clinic. Procedures compared four POC tests: one performed on oral fluids and three on fingerstick whole blood specimens. Specimens from participants with negative POC results were tested by EIA and pooled nucleic acid amplification testing (NAAT). McNemar's exact tests compared numbers of HIV-infected participants detected. RESULTS: Between February 2010 and May 2013, 104 men tested HIV-positive during 2479 visits. Eighty-two participants had concordant reactive POC results, 3 participants had concordant non-reactive POC tests but reactive EIAs, and 8 participants had acute infection. Of 12 participants with discordant POC results, OraQuick ADVANCE Rapid HIV-1/2 Antibody Test performed on oral fluids identified fewer infections than OraQuick performed on fingerstick (p = .005), Uni-Gold Recombigen HIV test (p = .01), and determine HIV-1/2 Ag/Ab combo (p = .005). CONCLUSIONS: These data confirm that oral fluid POC testing detects fewer infections than other methods and is best reserved for circumstances precluding fingerstick or venipuncture. Regardless of specimen type, POC tests failed to identify many HIV-infected MSM in Seattle. In populations with high HIV incidence, the currently approved POC antibody tests are inadequate unless supplemented with p24 antigen tests or NAAT.
BACKGROUND: Point-of-care (POC) rapid HIV tests have sensitivity during the "window period" comparable only to earliest generation EIAs. To date, it is unclear whether any POC test performs significantly better than others. OBJECTIVE: Compare abilities of POC tests to detect early infection in real time. STUDY DESIGN:Men who have sex with men (MSM) were recruited into a prospective, cross-sectional study at two HIV testing sites and a research clinic. Procedures compared four POC tests: one performed on oral fluids and three on fingerstick whole blood specimens. Specimens from participants with negative POC results were tested by EIA and pooled nucleic acid amplification testing (NAAT). McNemar's exact tests compared numbers of HIV-infectedparticipants detected. RESULTS: Between February 2010 and May 2013, 104 men tested HIV-positive during 2479 visits. Eighty-two participants had concordant reactive POC results, 3 participants had concordant non-reactive POC tests but reactive EIAs, and 8 participants had acute infection. Of 12 participants with discordant POC results, OraQuick ADVANCE Rapid HIV-1/2 Antibody Test performed on oral fluids identified fewer infections than OraQuick performed on fingerstick (p = .005), Uni-Gold Recombigen HIV test (p = .01), and determine HIV-1/2 Ag/Ab combo (p = .005). CONCLUSIONS: These data confirm that oral fluid POC testing detects fewer infections than other methods and is best reserved for circumstances precluding fingerstick or venipuncture. Regardless of specimen type, POC tests failed to identify many HIV-infected MSM in Seattle. In populations with high HIV incidence, the currently approved POC antibody tests are inadequate unless supplemented with p24 antigen tests or NAAT.
Authors: Freya Spielberg; Bernard M Branson; Gary M Goldbaum; David Lockhart; Ann Kurth; Anthony Rossini; Robert W Wood Journal: J Acquir Immune Defic Syndr Date: 2005-03-01 Impact factor: 3.731
Authors: Joanne Stekler; Janine Maenza; Claire E Stevens; Paul D Swenson; Robert W Coombs; Robert W Wood; Mary S Campbell; David C Nickle; Ann C Collier; Matthew R Golden Journal: Clin Infect Dis Date: 2006-12-20 Impact factor: 9.079
Authors: Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn Journal: J Infect Dis Date: 2005-03-30 Impact factor: 5.226
Authors: Joanne D Stekler; Heather D Baldwin; Michael W Louella; David A Katz; Matthew R Golden Journal: Sex Transm Infect Date: 2013-01-24 Impact factor: 3.519
Authors: Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch Journal: AIDS Date: 2003-09-05 Impact factor: 4.177
Authors: Cheng-Ting Tsai; Peter V Robinson; Felipe de Jesus Cortez; Maria L B Elma; David Seftel; Narges Pourmandi; Mark W Pandori; Carolyn R Bertozzi Journal: Proc Natl Acad Sci U S A Date: 2018-01-22 Impact factor: 11.205
Authors: Joanne D Stekler; Kenneth Tapia; Janine Maenza; Claire E Stevens; George A Ure; Joshua D O'Neal; Aric Lane; James I Mullins; Robert W Coombs; Sarah Holte; Ann C Collier Journal: AIDS Res Hum Retroviruses Date: 2018-06-13 Impact factor: 2.205
Authors: Kevin P Delaney; Jacqueline Rurangirwa; Shelley Facente; Teri Dowling; Mike Janson; Thomas Knoble; Annie Vu; Yunyin W Hu; Peter R Kerndt; Jan King; Susan Scheer Journal: J Acquir Immune Defic Syndr Date: 2016-01-01 Impact factor: 3.731
Authors: Joanne D Stekler; George Ure; Joshua D O'Neal; Aric Lane; Fred Swanson; Janine Maenza; Claire Stevens; Robert W Coombs; Joan Dragavon; Paul D Swenson; Matthew R Golden Journal: J Clin Virol Date: 2016-01-02 Impact factor: 3.168
Authors: David A Katz; Matthew R Golden; James P Hughes; Carey Farquhar; Joanne D Stekler Journal: J Acquir Immune Defic Syndr Date: 2018-08-15 Impact factor: 3.731